Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Vasc Surg. 2018 Feb 16;68(2):519–526. doi: 10.1016/j.jvs.2017.10.090

Table I.

Baseline Demographics, stratified by race. PVI: Peripheral vascular intervention.

Characteristic White (n=74,891, 83%) Black (n=15,527, 17%) P
Age 68 +/− 11.4 64 +/− 11.5 < .001
Male Sex 48,038 (64) 8,518 (55) < .001
Procedure Type: < .001
Bypass 26,579 (35) 4,684 (30)
PVI 44,152 (59) 8,310 (54)
Amputation 4,160 (6) 2,533 (16)
Indication < .001
Asymptomatic 4,046 (6) 483 (3)
claudication 27,706 (38) 3,634 (25)
rest pain 11,116 (15) 2,575 (25)
tissue loss 22,481 (31) 6,203 (43)
acute ischemia 7,000 (10) 1,356 (9)
CLTI 40,597 (56) 10,134 (70)
Smoking 61,506 (82) 11,628 (75) < .001
Prior PVI 35,111 (47) 6,145 (40) < .001
Medicaid/Self-Pay 4,898 (8) 2,128 (16) < .001
Hypertension 65,227 (87) 14,319 (93) < .001
Diabetes 37,396 (50) 10,292 (66) < .001
CAD 34,541 (46) 5,673 (37) < .001
CHF 12,933 (17) 3,310 (21) < .001
COPD 20,230 (27) 3,072 (20) < .001
BMI < .001
Underweight 2,932 (4) 774 (5)
Normal 22,317 (30) 4,836 (31)
Overweight 25,268 (34) 4,809 (31)
Obese 24,374 (33) 5,108 (33)
GFR<60 27,902 (37) 6,485 (42) < .001
Dialysis 3,918 (5) 2,609 (17) < .001
Case Urgency: < .001
Elective 60,327 (81) 11,739 (76)
Urgent 12,176 (16) 3,062 (20)
Emergent 2,154 (3) 596 (4)
Medications
Aspirin 53,978 (72) 10,481 (68) < .001
Statin 51,965 (70) 10,234 (66) < .001
P2Y12 inhibitor 26,184 (35) 5,433 (35)  0.69
Dual Antiplatelet 20,732 (28) 4,105 (27)  0.004
Any antiplatelet 59,430 (80) 11,809 (77) < .001
Volume Quintiles < .001
1 (<70/yr) 14,980 (20) 3,209 (21)
2(71–112/yr) 13,922 (19) 3,018 (19)
3 (115–166/yr) 16,418 (22) 3,171 (20)
4 (170–254/yr) 13,373 (18) 3,522 (23)
5 (>257/yr) 16,139 (22) 2,586 (17)